Literature DB >> 33313007

Acute Myocardial Infarction Secondary to Paradoxical Embolism.

Abdullah R Alenezi1, Muath Alanbaei2, Islam Abouelenein1.   

Abstract

Patent foramen ovale is a risk factor for systemic embolic events such as cryptogenic stroke. Far less commonly, patent foramen ovale is associated with non-cerebral systemic embolic events. Paradoxical coronary artery embolism is a rare and underdiagnosed cause of acute myocardial infarction. It should be considered in patients presenting with myocardial infarction and an otherwise low-risk profile for atherosclerotic coronary artery disease. We describe a case of paradoxical coronary artery embolism causing ST elevation myocardial infarction. Echocardiography demonstrated patent foramen ovale with a significant shunt. In addition to the treatment of the acute coronary event, patent foramen ovale closure was performed to prevent recurrent paradoxical embolic events. LEARNING POINTS: Coronary artery embolism is an established cause of acute coronary syndrome, but paradoxical coronary artery embolism causing myocardial infarction is rare and requires a high degree of clinical suspicion for diagnosis.Recognition of this condition is important as it has an influence on management and prognosis. A search for venous thrombosis and underlying prothrombotic conditions should be undertaken.Percutaneous device closure of the patent foramen ovale should be considered to prevent future embolic events. © EFIM 2020.

Entities:  

Keywords:  Coronary artery; embolism; myocardial infarction; paradoxical embolism

Year:  2020        PMID: 33313007      PMCID: PMC7727617          DOI: 10.12890/2020_001951

Source DB:  PubMed          Journal:  Eur J Case Rep Intern Med        ISSN: 2284-2594


  8 in total

Review 1.  Patent foramen ovale: anatomy, outcomes, and closure.

Authors:  Patrick A Calvert; Bushra S Rana; Anna C Kydd; Leonard M Shapiro
Journal:  Nat Rev Cardiol       Date:  2011-02-01       Impact factor: 32.419

2.  ESC working group position paper on myocardial infarction with non-obstructive coronary arteries.

Authors:  Stefan Agewall; John F Beltrame; Harmony R Reynolds; Alexander Niessner; Giuseppe Rosano; Alida L P Caforio; Raffaele De Caterina; Marco Zimarino; Marco Roffi; Keld Kjeldsen; Dan Atar; Juan C Kaski; Udo Sechtem; Per Tornvall
Journal:  Eur Heart J       Date:  2017-01-14       Impact factor: 29.983

3.  Successful removal of a paradoxical coronary embolus using an aspiration catheter.

Authors:  Andrew M Wilson; Reza Ardehali; Todd J Brinton; Alan C Yeung; Randall Vagelos
Journal:  Nat Clin Pract Cardiovasc Med       Date:  2006-11

4.  Cryptogenic Stroke and High-Risk Patent Foramen Ovale: The DEFENSE-PFO Trial.

Authors:  Pil Hyung Lee; Jae-Kwan Song; Jong S Kim; Ran Heo; Sahmin Lee; Dae-Hee Kim; Jong-Min Song; Duk-Hyun Kang; Sun U Kwon; Dong-Wha Kang; Dongwhane Lee; Hyuk Sung Kwon; Sung-Cheol Yun; Byung Joo Sun; Jae-Hyeong Park; Jae-Hwan Lee; Hye Seon Jeong; Hee-Jung Song; Jei Kim; Seung-Jung Park
Journal:  J Am Coll Cardiol       Date:  2018-03-12       Impact factor: 24.094

5.  Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke.

Authors:  Lars Søndergaard; Scott E Kasner; John F Rhodes; Grethe Andersen; Helle K Iversen; Jens E Nielsen-Kudsk; Magnus Settergren; Christina Sjöstrand; Risto O Roine; David Hildick-Smith; J David Spence; Lars Thomassen
Journal:  N Engl J Med       Date:  2017-09-14       Impact factor: 91.245

6.  Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke.

Authors:  Jeffrey L Saver; John D Carroll; David E Thaler; Richard W Smalling; Lee A MacDonald; David S Marks; David L Tirschwell
Journal:  N Engl J Med       Date:  2017-09-14       Impact factor: 91.245

7.  Closure of patent foramen ovale versus medical therapy after cryptogenic stroke.

Authors:  John D Carroll; Jeffrey L Saver; David E Thaler; Richard W Smalling; Scott Berry; Lee A MacDonald; David S Marks; David L Tirschwell
Journal:  N Engl J Med       Date:  2013-03-21       Impact factor: 91.245

Review 8.  Patent Foramen Ovale Closure in 2019.

Authors:  Joel P Giblett; Omar Abdul-Samad; Leonard M Shapiro; Bushra S Rana; Patrick A Calvert
Journal:  Interv Cardiol       Date:  2019-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.